- Report
- November 2025
- 160 Pages
Global
From €2981EUR$3,358USD£2,583GBP
€3507EUR$3,950USD£3,038GBP
- Report
- November 2025
- 160 Pages
Global
From €2981EUR$3,358USD£2,583GBP
€3507EUR$3,950USD£3,038GBP
- Report
- October 2025
- 160 Pages
Global
From €2981EUR$3,358USD£2,583GBP
€3507EUR$3,950USD£3,038GBP
- Report
- October 2025
- 160 Pages
Global
From €2981EUR$3,358USD£2,583GBP
€3507EUR$3,950USD£3,038GBP
- Report
- August 2025
- 150 Pages
Global
From €2981EUR$3,358USD£2,583GBP
€3507EUR$3,950USD£3,038GBP
- Report
- March 2026
- 198 Pages
Global
From €4434EUR$4,995USD£3,842GBP
- Report
- January 2026
- 200 Pages
Global
From €4434EUR$4,995USD£3,842GBP
- Report
- February 2026
- 89 Pages
Global
From €3500EUR$4,223USD£3,139GBP
- Report
- September 2025
- 142 Pages
Global
From €3500EUR$4,223USD£3,139GBP
- Report
- August 2025
- 98 Pages
Global
From €3500EUR$4,223USD£3,139GBP
- Report
- September 2025
- 130 Pages
Global
From €4305EUR$4,850USD£3,730GBP
- Report
- September 2025
- 150 Pages
Global
From €4305EUR$4,850USD£3,730GBP
- Report
- February 2026
- 170 Pages
Global
From €4305EUR$4,850USD£3,730GBP
- Report
- March 2026
- 138 Pages
Global
From €4305EUR$4,850USD£3,730GBP
- Report
- March 2026
- 135 Pages
Global
From €4305EUR$4,850USD£3,730GBP
- Report
- November 2025
- 52 Pages
Global
From €6658EUR$7,500USD£5,769GBP
- Report
- November 2025
Global
From €6658EUR$7,500USD£5,769GBP
- Report
- October 2025
- 85 Pages
Global
From €4305EUR$4,850USD£3,730GBP
- Report
- July 2025
- 132 Pages
Global
From €4305EUR$4,850USD£3,730GBP
- Report
- June 2025
- 109 Pages
Global
From €3063EUR$3,450USD£2,654GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more